SONGYI-REBECCA TING: Open Payments
NPI 1689301228 · JERSEY CITY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$399 in 16 payments from 8 companies in 2025. Trend: 2023 $26 · 2024 $162 · 2025 $399
Food & beverage: $399
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 4 | $176 |
| Fresenius USA Marketing, Inc. | 3 | $60 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| Amgen Inc. | 2 | $34 |
| Otsuka America Pharmaceutical, Inc. | 2 | $30 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $29 |
| Travere Therapeutics, Inc. | 1 | $18 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
Products named: XPHOZAH 30 MG, VELPHORO, IBSRELA, BENLYSTA, REPATHA, JYNARQUE, Kerendia, JARDIANCE.
Industry payments across NJ — which companies pay providers there.
